LC-HRMS based metabolomics screening model to detect various β-agonists treatments in bovines

Metabolomics

Volumn 11, Issue 2, 2015, Pages 403-411

  Dervilly Pinel, Gaud ^a   Chereau, Sylvain ^a   Cesbron, Nora ^a   Monteau, Fabrice ^a   Le Bizec, Bruno ^a  

^a LUNAM UNIVERSITÉ   (France)

Author keywords

Anabolic practices; Bovines; LC HRMS metabolomics; Low dose cocktails; Screening; Urine; agonists

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CIMATEROL; CLENBUTEROL; LEUCINE; MABUTEROL; MEDROXYPROGESTERONE ACETATE; METHYLTESTOSTERONE; PONASTERONE A; RACTOPAMINE; STANOZOLOL; TRIAMCINOLONE; ZILPATEROL;

ANIMAL EXPERIMENT; ARTICLE; BOVINE; CALF (BOVINE); CONTROLLED STUDY; DATA PROCESSING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERNAL CONSISTENCY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MATHEMATICAL PHENOMENA; METABOLOMICS; NONHUMAN; PREDICTION; QUALITY CONTROL; URINALYSIS;

EID: 84946401714     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-014-0705-3     Document Type: Article

References (25)

1. Antignac, J. P., Courant, F., Pinel, G., Bichon, E., Monteau, F., Elliott, C., et al. (2011). Mass spectrometry-based metabolomics applied to the chemical safety of food. TrAC, Trends in Analytical Chemistry,30(2), 292–301. doi:10.1016/j.trac.2010.11.003.
2. Boyard-Kieken, F., Dervilly-Pinel, G., Garcia, P., Paris, A. C., Popot, M. A., le Bizec, B., et al. (2011). Comparison of different liquid chromatography stationary phases in LC-HRMS metabolomics for the detection of recombinant growth hormone doping control. [Comparative Study Research Support, Non-U.S. Gov’t]. Journal of Separation Science,34(24), 3493–3501. doi:10.1002/jssc.201100223.
3. Council Decision 2002/657/EC implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results (2002). Official Journal of the European Union.
4. Council Directive 88/146/EEC prohibiting the use livestock farming of certain substances having a hormonal action Official Journal of the European Union (1988). (16), 16-18.
5. Council Directive 96/23/EU on measures to monitor certain substances and residues thereof in live animals and animal products Official Journal of the European Union L125 (1996). 96/23/EC(10).
6. Courant, F., Pinel, G., Bichon, E., Monteau, F., Antignac, J. P., & Le Bizec, B. (2009). Development of a metabolomic approach based on liquid chromatography-high resolution mass spectrometry to screen for clenbuterol abuse in calves. [Research Support, Non-U.S. Gov’t]. Analyst,134(8), 1637–1646. doi:10.1039/b901813a.
7. Cunningham, R., Mooney, M., Xia, X., Crooks, S., Matthews, D., O’Keefe, M., et al. (2009). Feasibility of a clinical chemical analysis approach to predict misuse of growth promoting hormones in cattle. Analytical Chemistry,81, 977.
8. Dervilly-Pinel, G., Weigel, S., Lommen, A., Chereau, S., Rambaud, L., Essers, M., et al. (2011). Assessment of two complementary liquid chromatography coupled to high resolution mass spectrometry metabolomics strategies for the screening of anabolic steroid treatment in calves. [Research Support, Non-U.S. Gov’t]. Analytica Chimica Acta,700(1–2), 144–154. doi:10.1016/j.aca.2011.02.008.
9. Dervilly-Pinel, G., Courant, F., Chereau, S., Royer, A., Boyard-Kieken, F., Antignac, J., et al. (2012). Metabolomics in food analysis: Application to the control of forbidden substances. Drug Testing and Analysis,4, 10.
10. Jacob, C. C., Dervilly-Pinel, G., Biancotto, G., & Le Bizec, B. (2013). Evaluation of specific gravity as normalization strategy for cattle urinary metabolome analysis. Metabolomics,. doi:10.1007/s11306-013-0604-z.
11. Jacob, C., Dervilly-Pinel, G., Biancotto, G., Monteau, F., & Le Bizec, B. (2014). Global urine fingerprinting by LC-ESI(+)-HRMS for better characterization of metabolic pathway disruption upon anabolic practices in bovine. Metabolomics,. doi:10.1007/s11306-014-0685-3.
12. Kaabia, Z., Dervilly-Pinel, G., Popot, M. A., Bailly-Chouriberry, L., Plou, P., Bonnaire, Y., et al. (2014). Monitoring the endogenous steroid profile disruption in urine and blood upon nandrolone administration: an efficient and innovative strategy to screen for nandrolone abuse in horses. Drug Testing and Analysis,. doi:10.1002/dta.1520.
13. Kieken, F., Pinel, G., Antignac, J. P., Monteau, F., Christelle Paris, A., Popot, M. A., et al. (2009). Development of a metabonomic approach based on LC-ESI-HRMS measurements for profiling of metabolic changes induced by recombinant equine growth hormone in horse urine. [Research Support, Non-U.S. Gov’t Validation Studies]. Analytical and Bioanalytical Chemistry,394(8), 2119–2128. doi:10.1007/s00216-009-2912-8.
14. Kieken, F., Pinel, G., Antignac, J., Garcia, P., Popot, M., Grall, M., et al. (2011). Development and application of a metabolomic approach based on liquid chromatography-high resolution mass spectrometry to reveal an illegal administration of recombinant equine growth hormone in horse from urinary and plasmatic biological signatures. Metabolomics,7, 9.
15. Le Bizec, B., Pinel, G., & Antignac, J. P. (2009). Review: Options for veterinary drug analysis using mass spectrometry. Journal of Chromatography A,1216, 8016–8034.
16. McGrath, T. F., van Meeuwen, J. A., Massart, A. C., de Pauw, E., Delahaut, P., Buijs, J., et al. (2013). Effect-based proteomic detection of growth promoter abuse. [Evaluation Studies Research Support, Non-U.S. Gov’t]. Analytical and Bioanalytical Chemistry,405(4), 1171–1179. doi:10.1007/s00216-012-6534-1.
17. Mooney, M. H., Bergwerff, A. A., van Meeuwen, J. A., Luppa, P. B., & Elliott, C. T. (2009). Biosensor-based detection of reduced sex hormone-binding globulin binding capacities in response to growth-promoter administrations. [Research Support, Non-U.S. Gov’t]. Analytica Chimica Acta,637(1–2), 235–240. doi:10.1016/j.aca.2008.08.024.
18. Nebbia, C., Urbani, A., Carletti, M., Gardini, G., Balbo, A., Bertarelli, D., et al. (2011). Novel strategies for tracing the exposure of meat cattle to illegal growth-promoters [Review]. Veterinary Journal,189(1), 34–42. doi:10.1016/j.tvjl.2010.06.016.
19. Parker, C. E., & Borchers, C. H. (2014). Mass spectrometry based biomarker discovery, verification, and validation – Quality assurance and control of protein biomarker assays. Molecular Oncology,. doi:10.1016/j.molonc.2014.03.006.
20. Pinel, G., Weigel, S., Antignac, J. P., Mooney, M. H., Elliott, C., Nielen, M. W. F., et al. (2010). Targeted and untargeted profiling of biological fluids to screen for anabolic practices in cattle. TrAC, Trends in Analytical Chemistry,29(11), 1269–1280. doi:10.1016/j.trac.2010.06.010.
21. Pinel, G., Weigel, S., Lommen, A., Chéreau, S., Rambaud, L., Essers, M., et al. (2011). Assessment of two complementary LC-HRMS metabolomics strategies for the screening of anabolic steroid treatment in calves. Analytica Chimica Acta,700, 10.
22. Regal, P., Anizan, S., Antignac, J. P., Le Bizec, B., Cepeda, A., & Fente, C. (2011). Metabolomic approach based on liquid chromatography coupled to high resolution mass spectrometry to screen for the illegal use of estradiol and progesterone in cattle. [Research Support, Non-U.S. Gov’t]. Analytica Chimica Acta,700(1–2), 16–25. doi:10.1016/j.aca.2011.01.005.
23. Riedmaier, I., & Pfaffl, M. W. (2013). Transcriptional biomarkers—high throughput screening, quantitative verification, and bioinformatical validation methods. Methods,59(1), 3–9. doi:10.1016/j.ymeth.2012.08.012.
24. Riedmaier, I., Becker, C., Pfaffl, M. W., & Meyer, H. H. (2009). The use of omic technologies for biomarker development to trace functions of anabolic agents. [Review]. Journal of Chromatography A,1216(46), 8192–8199. doi:10.1016/j.chroma.2009.01.094.
25. Rijk, J., Lommen, A., Essers, M., Groot, M. J., Van Hende, J., Doeswijk, T., et al. (2009). Metabolomics approach to anabolic steroid urine profiling of bovines treated with prohormones. Analytical Chemistry,81, 11.